Anant Madabhushi, PhD

Biography

Anant Madabhushi, PhD, holds a primary faculty appointment in the Department of Biomedical Engineering and secondary appointments in the Departments of Radiology and Imaging Sciences, Biomedical Informatics (BMI) and Pathology. Dr. Madabhushi serves as executive director for the Emory Empathetic AI for Health Institute.

Prior to joining Emory, Dr. Madabhushi was at Case Western Reserve University, where he was the director of the Center for Computational Imaging and Personalized Diagnostics and Donnell Institute Professor, Department of Biomedical Engineering. He was also a research health scientist at the Louis Stokes Cleveland Veterans Administration Medical Center.

In 2021, he was honored as one of Crain's Cleveland Business Notable Entrepreneurs of the year and also was conferred a Faculty Distinguished Research Award by Case Western Reserve University. His work on using AI for addressing health disparities, especially in identifying differences in appearance of prostate cancer between Black and white men, received national attention in 2020.

Dr. Madabhushi is a Fellow of the American Association for the Advancement of Science, a Fellow of the American Institute of Medical and Biological Engineering, a Fellow of the Institute for Electrical and Electronic Engineers and a Fellow of the National Academy of Inventors. In 2017, he received the IEEE Engineering in Medicine and Biology Society award for technical achievements in computational imaging and digital pathology.

Education

Dr. Madabhushi earned a Master of Science in Biomedical Engineering from the University of Texas at Austin and a PhD in Bioengineering from the University of Pennsylvania.

Titles & Roles

• Professor, Wallace H. Coulter Department of Biomedical Engineering

  Georgia Institute of Technology and Emory University
• Executive Director

  Emory Empathetic AI for Health Institute

Research

Dr. Madabhushi has authored more than 450 peer-reviewed publications and holds more than 100 patents either issued or pending in the areas of artificial intelligence, radiomics, computational pathology, medical image analysis and computer vision. His team has been applying these approaches for diagnosis, prognosis and prediction of treatment response across a spectrum of disease including different types of cancers, cardiovascular disease, kidney disease and ophthalmology.

He has secured almost $80 million in grant funding and co-founded three companies. He has been involved in several sponsored research and industry partnerships with medical imaging and pharmaceutical companies. In addition, more than 30 technologies developed by Dr. Madabhushi's team have been licensed.

Grants